Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Major Depressive Disorder With Psychotic Features With Quetiapine Monotherapy; Quetiapine and Citalopram; or Haloperidol and Citalopram

NCT00174603 is registered in ClinicalTrials.gov with Rush University Medical Center as lead sponsor.

NCT NCT00174603
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00174603 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Major Depressive Disorder With Psychotic Features With Quetiapine Monotherapy; Quetiapine and Citalopram; or Haloperidol and Citalopram
Lead sponsor
Rush University Medical Center
Phase
Phase 3
Overall status
Terminated
Start date
August 31, 2005
Completion date
January 31, 2007
Enrollment
60
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

major depression with psychotic features